US Stock MarketDetailed Quotes

Arcutis Biotherapeutics (ARQT)

Watchlist
  • 21.690
  • +1.000+4.83%
Close May 13 15:59 ET
  • 20.846
  • -0.844-3.89%
Pre 04:23 ET
2.71BMarket Cap-1084.50P/E (TTM)

Arcutis Biotherapeutics (ARQT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
60.07%105.4M
91.34%376.07M
81.48%129.5M
121.69%99.22M
164.13%81.5M
32.84%65.85M
229.74%196.54M
427.58%71.36M
17.44%44.76M
494.57%30.86M
Operating revenue
65.08%105.4M
123.41%372.07M
83.83%127.5M
121.69%99.22M
164.13%81.5M
196.01%63.85M
470.62%166.54M
412.79%69.36M
451.92%44.76M
546.92%30.86M
Cost of revenue
10.80%9.78M
91.84%36.7M
69.27%11.69M
57.82%8.69M
116.28%7.49M
171.19%8.83M
283.56%19.13M
207.44%6.91M
365.57%5.5M
346.39%3.46M
Gross profit
67.70%95.61M
91.29%339.38M
82.79%117.82M
130.65%90.53M
170.18%74.01M
23.11%57.02M
224.82%177.41M
471.41%64.46M
6.30%39.25M
520.62%27.39M
Operating expense
28.40%104.7M
14.97%351.6M
37.93%99.43M
4.71%82.01M
14.40%88.62M
4.63%81.55M
3.41%305.81M
-0.50%72.09M
6.08%78.32M
8.84%77.47M
Selling and administrative expenses
15.74%74.08M
19.69%274.55M
37.10%78.98M
6.10%62.4M
18.90%69.17M
16.80%64M
23.90%229.39M
18.35%57.61M
23.58%58.82M
26.58%58.17M
Research and development costs
74.58%30.63M
0.83%77.05M
41.24%20.45M
0.53%19.6M
0.80%19.45M
-24.19%17.54M
-30.89%76.42M
-39.10%14.48M
-25.67%19.5M
-23.48%19.3M
Operating profit
62.95%-9.09M
90.48%-12.23M
340.92%18.39M
121.82%8.53M
70.82%-14.61M
22.43%-24.53M
46.75%-128.4M
87.52%-7.63M
-5.86%-39.07M
24.99%-50.08M
Net non-operating interest income expense
-370.34%-2.09M
71.15%-3.19M
-44.25%5.9M
53.84%-3.07M
59.53%-3.03M
94.05%-445K
35.78%-11.04M
122.40%10.58M
11.99%-6.65M
-1.84%-7.48M
Non-operating interest income
-10.33%2.28M
-44.83%8.9M
----
----
----
--2.54M
28.83%16.13M
----
----
----
Non-operating interest expense
46.48%4.37M
-55.52%12.08M
-45.94%3M
-53.84%3.07M
-59.53%3.03M
-60.13%2.98M
-8.56%27.17M
-28.48%5.55M
-11.99%6.65M
1.84%7.48M
Other net income (expense)
-110.36%-20K
842.55%443K
52.13%-6.42M
-51.34%2.04M
-59.92%2.1M
-95.23%193K
106.43%47K
-36.19%-13.41M
53.69%4.18M
67.54%5.23M
Other non- operating income (expenses)
-110.36%-20K
842.55%443K
52.13%-6.42M
-51.34%2.04M
-59.92%2.1M
-95.23%193K
106.43%47K
-36.19%-13.41M
53.69%4.18M
67.54%5.23M
Income before tax
54.80%-11.2M
89.26%-14.97M
270.71%17.87M
118.03%7.49M
70.30%-15.54M
29.31%-24.78M
46.19%-139.39M
84.21%-10.47M
0.49%-41.54M
26.28%-52.33M
Income tax
-66.67%93K
80.99%1.17M
45.51%470K
80K
342K
-13.89%279K
-79.22%647K
1,192.00%323K
0
0
Net income
54.93%-11.3M
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
Net income continuous Operations
54.93%-11.3M
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
Minority interest income
Net income attributable to the parent company
54.93%-11.3M
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
54.93%-11.3M
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
Basic earnings per share
55.00%-0.09
88.79%-0.13
255.56%0.14
118.18%0.06
69.05%-0.13
37.50%-0.2
69.31%-1.16
87.50%-0.09
54.79%-0.33
63.79%-0.42
Diluted earnings per share
55.00%-0.09
88.79%-0.13
244.44%0.13
116.69%0.0558
69.05%-0.13
37.50%-0.2
69.31%-1.16
87.50%-0.09
54.22%-0.3342
63.79%-0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 60.07%105.4M91.34%376.07M81.48%129.5M121.69%99.22M164.13%81.5M32.84%65.85M229.74%196.54M427.58%71.36M17.44%44.76M494.57%30.86M
Operating revenue 65.08%105.4M123.41%372.07M83.83%127.5M121.69%99.22M164.13%81.5M196.01%63.85M470.62%166.54M412.79%69.36M451.92%44.76M546.92%30.86M
Cost of revenue 10.80%9.78M91.84%36.7M69.27%11.69M57.82%8.69M116.28%7.49M171.19%8.83M283.56%19.13M207.44%6.91M365.57%5.5M346.39%3.46M
Gross profit 67.70%95.61M91.29%339.38M82.79%117.82M130.65%90.53M170.18%74.01M23.11%57.02M224.82%177.41M471.41%64.46M6.30%39.25M520.62%27.39M
Operating expense 28.40%104.7M14.97%351.6M37.93%99.43M4.71%82.01M14.40%88.62M4.63%81.55M3.41%305.81M-0.50%72.09M6.08%78.32M8.84%77.47M
Selling and administrative expenses 15.74%74.08M19.69%274.55M37.10%78.98M6.10%62.4M18.90%69.17M16.80%64M23.90%229.39M18.35%57.61M23.58%58.82M26.58%58.17M
Research and development costs 74.58%30.63M0.83%77.05M41.24%20.45M0.53%19.6M0.80%19.45M-24.19%17.54M-30.89%76.42M-39.10%14.48M-25.67%19.5M-23.48%19.3M
Operating profit 62.95%-9.09M90.48%-12.23M340.92%18.39M121.82%8.53M70.82%-14.61M22.43%-24.53M46.75%-128.4M87.52%-7.63M-5.86%-39.07M24.99%-50.08M
Net non-operating interest income expense -370.34%-2.09M71.15%-3.19M-44.25%5.9M53.84%-3.07M59.53%-3.03M94.05%-445K35.78%-11.04M122.40%10.58M11.99%-6.65M-1.84%-7.48M
Non-operating interest income -10.33%2.28M-44.83%8.9M--------------2.54M28.83%16.13M------------
Non-operating interest expense 46.48%4.37M-55.52%12.08M-45.94%3M-53.84%3.07M-59.53%3.03M-60.13%2.98M-8.56%27.17M-28.48%5.55M-11.99%6.65M1.84%7.48M
Other net income (expense) -110.36%-20K842.55%443K52.13%-6.42M-51.34%2.04M-59.92%2.1M-95.23%193K106.43%47K-36.19%-13.41M53.69%4.18M67.54%5.23M
Other non- operating income (expenses) -110.36%-20K842.55%443K52.13%-6.42M-51.34%2.04M-59.92%2.1M-95.23%193K106.43%47K-36.19%-13.41M53.69%4.18M67.54%5.23M
Income before tax 54.80%-11.2M89.26%-14.97M270.71%17.87M118.03%7.49M70.30%-15.54M29.31%-24.78M46.19%-139.39M84.21%-10.47M0.49%-41.54M26.28%-52.33M
Income tax -66.67%93K80.99%1.17M45.51%470K80K342K-13.89%279K-79.22%647K1,192.00%323K00
Net income 54.93%-11.3M88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M
Net income continuous Operations 54.93%-11.3M88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M
Minority interest income
Net income attributable to the parent company 54.93%-11.3M88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 54.93%-11.3M88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M
Basic earnings per share 55.00%-0.0988.79%-0.13255.56%0.14118.18%0.0669.05%-0.1337.50%-0.269.31%-1.1687.50%-0.0954.79%-0.3363.79%-0.42
Diluted earnings per share 55.00%-0.0988.79%-0.13244.44%0.13116.69%0.055869.05%-0.1337.50%-0.269.31%-1.1687.50%-0.0954.22%-0.334263.79%-0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More